Simvastatin cream versus steroid cream for patchy hair loss
Treatments studied
Part of Skin clinical trials.
This trial compares a cholesterol-lowering cream (simvastatin) with a standard steroid cream to treat patchy hair loss from alopecia areata. It aims to find a gentler, more effective way to help hair regrow on the scalp.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have patchy hair loss on less than half of your scalp
- You have not used any hair loss treatment (topical or oral) in the last 2 months
- You are not pregnant or breastfeeding
- You do not have other causes of hair loss, such as thyroid or immune disorders
- You have no active infection, skin disease, or scars (keloids) in the affected area
- You are not allergic to the study medications
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new cream or lotion for people with patchy hair loss (alopecia areata) that covers less than half of the scalp. It aims to see if the treatment helps hair grow back in those patches.
This study compares two treatments for patchy hair loss on the scalp: a vitamin D-like cream (calcipotriol) and steroid injections (intralesional steroids). It aims to see which is more effective at regrowing hair in adults with less than half of the scalp affected.
This study tests whether a methotrexate lotion or minoxidil lotion is better at regrowing hair in people with patchy hair loss on the scalp. You will use one of the treatments for a period of time, and the doctors will check your progress.
This trial tests if microneedling with either lactic acid, vitamin D3, or a steroid cream helps regrow hair in people with patchy alopecia areata (small bald spots).
This study uses a special UV light to look at your scalp in a new way. It may help doctors better understand and monitor alopecia areata (a condition that causes patchy hair loss). Participation involves only imaging, no drugs or invasive procedures.
This Phase 2 trial tests dupilumab (an injection medicine) to regrow hair in people with alopecia areata, a condition where the immune system attacks hair follicles. It may help by reducing the immune-related inflammation linked to hair loss.
Hear when a new Alopecia Areata trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.